AES Survey to Assess the Impact of COVID-19 on Epilepsy Care – Participate by May 25!
This quick (6-8 min) survey gathers member experiences around epilepsy care during COVID-19, including:
- What providers are seeing in COVID patients and people with epilepsy (PWE)
- Pharmacotherapy and medication shortage experiences
- Issues impacting patient access to care and providers’ ability to provide care
Your input will help inform all epilepsy care providers and their patients as the COVID-19 landscape evolves.